glutamine has been researched along with Liver Dysfunction in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (47.95) | 18.7374 |
1990's | 6 (8.22) | 18.2507 |
2000's | 7 (9.59) | 29.6817 |
2010's | 19 (26.03) | 24.3611 |
2020's | 6 (8.22) | 2.80 |
Authors | Studies |
---|---|
Claeys, W; Geerts, A; Ghesquière, B; Lefere, S; Van Hoecke, L; Van Imschoot, G; Van Steenkiste, C; Van Vlierberghe, H; Van Wonterghem, E; Vandenbroucke, RE | 1 |
Braissant, O; Cudalbu, C; McLin, VA; Oldani, G; Rackayova, V; Sessa, D; Simicic, D; Toso, C | 1 |
Allegri, G; Burke, KE; Cederbaum, SD; Häberle, J; Lipshutz, GS; Liu, XB; Martini, PGV; Truong, B; Zhu, X | 1 |
Holeček, M | 1 |
Braissant, O; Cudalbu, C; McLin, VA; Rackayova, V; Rougemont, AL | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Braissant, O; Capobianco, D; Cudalbu, C; DeMorrow, S; Flatt, E; Grosse, J; Mastromarino, P; McLin, VA; McMillin, M; Rackayová, V | 1 |
Burjonrappa, S; Miller, M | 1 |
Cai, W; Feng, Y; Tang, QY; Tao, YX; Wang, Y; Wu, J | 2 |
Cooper, AJ; Kuhara, T | 1 |
Ott, P; Vilstrup, H | 1 |
Bosoi, CR; Huynh, J; Marin, H; Parent-Robitaille, C; Rose, CF; Tremblay, M; Zwingmann, C | 1 |
Dursun, R; Ekinci, A; Ekinci, C; Güloğlu, C; Gündüz, E; İbiloğlu, İ; İçer, M; Ülger, BV; Uslukaya, Ö; Zengin, Y | 1 |
Einsele, H; Fuji, S; Kapp, M; Savani, BN | 1 |
Balart, LA; Parekh, PJ | 1 |
Katayama, K | 1 |
Aldámiz-Echevarría, L; De Las Heras, J; Delgado, TC; Martínez-Chantar, ML | 1 |
Ju, S; Li, Y; Mei, L; Qiang, J; Zhao, S | 1 |
Häberle, J; Marquardt, T; Vermeulen, T | 1 |
Dejong, CH; Jalan, R; Olde Damink, SW | 1 |
Blázovics, A; Gero, D; Harsányi, L; Hegedus, V; Kiss, A; Kupcsulik, P; Lotz, G; Módis, K; Ónody, P; Stangl, R; Szabó, C; Szijártó, A; Tamás, J; Tátrai, M | 1 |
Hirayama, A; Honma, M; Igarashi, K; Ikeda, S; Kashikura, K; Kawata, S; Mori, M; Nihei, K; Otsuka, M; Saito, T; Sakuragawa, T; Soga, T; Suematsu, M; Sugimoto, M; Suzuki, H; Tomita, M; Tsuji, S; Watanabe, H; Yamamoto, T; Yatomi, Y; Yoshida, H | 1 |
Walker, V | 1 |
Hanada, S; Harada, M; Kwan, R; Li, DH; Omary, MB; Strnad, P | 1 |
An, J; Ishikawa, N; Kazama, S; Kurokawa, T; Nonami, T; Shimomura, Y; Sugiyama, S; Tsunekawa, K | 1 |
Fang, J; Feng, YN; Shi, Q; Zhang, SC | 1 |
Chan, DC; Chang, TM; Hwang, JM; Lu, RH; Tsai, LM; Tsao, TY; Tsou, SS | 1 |
CAESAR, J | 1 |
BOSCHETTI, J; LAPLACETTE, RM; PICCALUGA, AJ; RUBIO, HH | 1 |
WU, C | 2 |
Hutchinson, JH; Jolley, RL; Labby, DH | 1 |
RAULDUMM, F; SCHAPOSNIK, F | 1 |
DUMM, FR; SCHAPOSNIK, F | 1 |
KJERULF, K; MUNCK, BG | 1 |
Bonte, W; Buerrig, KF; Daldrup, T; Jacob, B; Madea, B; Musshoff, F; Schmidt, P; Schoenemeier, S | 1 |
Cai, W; Hong, L; Shi, C; Tang, Q; Wu, J | 1 |
Igari, J; Tauchi, K | 1 |
Goić, A; González, M; Velasco, C; Velasco, M | 1 |
Gerok, W; Häussinger, D | 2 |
Kato, Y; Kouno, M; Miyashita, M; Mizuno, H; Okabe, K; Sato, A; Suzuki, H; Suzuki, M; Tominaga, T | 1 |
Cheng, CC; Egashira, Y; Katayama, T; Ohta, T; Sanada, H | 1 |
Bado, M; Bruno, C; DiMauro, S; DiRocco, M; Lamba, LD; Marino, C; Minetti, C; Shanske, S; Stella, G; Tsujino, S; van Diggelen, OP | 1 |
Babu, R; Drake, DP; Eaton, S; Pierro, A; Spitz, L | 1 |
Capria, S; Grieco, G; Iori, AP; Muscaritoli, M; Rossi Fanelli, F | 1 |
Orlowski, M | 1 |
Kitova, R; Popova, M; Uznov, I | 1 |
Martini, GA | 1 |
Ganda, OP; Ruderman, NB | 1 |
Ackerman, Z; Farrow, NA; Kreis, R; Ross, BD | 1 |
Helton, WS; Hong, RW; Robinson, MK; Rounds, JD; Wilmore, DW | 1 |
Blei, AT | 1 |
Bates, TE; Gadian, DG; Kauppinen, RA; Williams, SR | 1 |
Tønnesen, K | 1 |
Gerok, W; Häussinger, D; Kaiser, S | 1 |
Morimoto, Y; Tsuji, T; Ukida, M | 1 |
Gilon, E; Weiss, P | 1 |
Nagashima, H; Ukida, M; Usui, H | 1 |
Kattermann, R; Schenzer, R; Schlaeger, R | 1 |
Proelss, HF; Wright, BW | 1 |
Cooper, AJ; Duffy, TE; Meister, A | 1 |
Gal'perin, EI; Semendiaeva, ME; Tareev, EM | 1 |
Ilinich, VK; Plastun, FF | 1 |
Cavanagh, JB; Kyu, MH; Zamora, AJ | 1 |
Duffy, TE; Plum, F; Vergara, F | 1 |
Best, SM; Hooper, PT; Murray, DR | 1 |
Beyermann, K; Weise, K | 1 |
Brink, P; Harum, A; Zacarias, J | 1 |
Debov, SS; Khokhlov, AP; Mardashev, SR | 1 |
Hierholzer, G | 1 |
12 review(s) available for glutamine and Liver Dysfunction
Article | Year |
---|---|
Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement.
Topics: Amino Acids, Branched-Chain; Ammonia; Chelating Agents; Contraindications; Dermatitis, Atopic; Dietary Supplements; Filaggrin Proteins; Free Radical Scavengers; Glutamine; Histamine; Histidine; Humans; Hypertrophy; Liver; Liver Diseases; Metabolic Syndrome; Nervous System Diseases; Organ Preservation Solutions | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.
Topics: Amidohydrolases; Aminohydrolases; Ammonia; Animals; Biomarkers; Carbon; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Keto Acids; Ketoglutaric Acids; Kynurenine; Liver Diseases; Mammals; Methionine; Nitrogen; Sulfur; Transaminases; Urea Cycle Disorders, Inborn | 2014 |
Cerebral effects of ammonia in liver disease: current hypotheses.
Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Brain Edema; Diffusion; Energy Metabolism; gamma-Aminobutyric Acid; Glutamine; Glycolysis; Hepatic Encephalopathy; Humans; Hyperammonemia; Ketoglutarate Dehydrogenase Complex; Lactates; Liver Diseases; Mitochondria; Models, Biological; Receptors, GABA; Receptors, Glutamate; Synaptic Transmission | 2014 |
Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Topics: Allografts; Body Mass Index; Comorbidity; Diabetes Mellitus; Energy Intake; Fatty Acids, Omega-3; Glutamine; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hyperglycemia; Liver Diseases; Malnutrition; Metabolic Syndrome; Nutritional Support; Obesity; Parenteral Nutrition; Postoperative Care; Postoperative Complications; Prognosis; Transplantation Conditioning | 2015 |
Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy.
Topics: Ammonia; Animals; Astrocytes; Blood-Brain Barrier; Chronic Disease; gamma-Aminobutyric Acid; Glutamine; Hepatic Encephalopathy; Humans; Liver Diseases | 2015 |
An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.
Topics: Ammonia; Animals; Benzoates; Drug Design; Glutamine; Humans; Liver Cirrhosis; Liver Diseases; Liver Failure, Acute; Nitrogen; Phenylacetates; Phenylbutyrates; Urea Cycle Disorders, Inborn | 2017 |
Interorgan ammonia trafficking in liver disease.
Topics: Amino Acids; Ammonia; Animals; Brain; Glutamine; Humans; Hyperammonemia; Intestinal Mucosa; Intestines; Kidney; Liver Circulation; Liver Diseases; Muscle, Skeletal | 2009 |
Severe hyperammonaemia in adults not explained by liver disease.
Topics: Adult; Amino Acids; Ammonia; Biological Transport; Blood-Brain Barrier; Brain; Glutamine; Humans; Hyperammonemia; Liver; Liver Diseases; Nitrogen; Urea; Urea Cycle Disorders, Inborn | 2012 |
Nutritional and metabolic support in patients undergoing bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Child; Fatty Acids; Glutamine; Graft vs Host Disease; Hematologic Diseases; Humans; Liver Diseases; Neoplasms; Nutritional Support | 2002 |
Possible role of glutathione in transport processes.
Topics: Acidosis; Amino Acids; Animals; Biological Transport, Active; Brain; Capillaries; Cell Membrane; Choroid Plexus; Ciliary Body; Epithelium; gamma-Glutamyltransferase; Glutamine; Glutathione; Humans; Intestinal Mucosa; Kidney; Lens, Crystalline; Liver Diseases; Organ Specificity; Peptide Synthases; Pyrrolidonecarboxylic Acid | 1976 |
[Treatment of acute hepatic insufficiency (a survey of the literature)].
Topics: Acute Disease; Adenosine Triphosphate; Arginine; Chemical and Drug Induced Liver Injury; Exchange Transfusion, Whole Blood; Folic Acid; Gastrointestinal Hemorrhage; Glutamine; Hepatic Encephalopathy; Humans; Hyperkalemia; Liver; Liver Diseases; Potassium Chloride; Radiation Injuries; Spironolactone; Thiamine Pyrophosphate; Thioctic Acid | 1972 |
4 trial(s) available for glutamine and Liver Dysfunction
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Glutamine supplementation in preterm infants receiving parenteral nutrition leads to an early improvement in liver function.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Double-Blind Method; Female; gamma-Glutamyltransferase; Gestational Age; Glutamine; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Liver Diseases; Male; Parenteral Nutrition; Time Factors | 2013 |
Protective effect of parenteral glutamine supplementation on hepatic function in very low birth weight infants.
Topics: Blood Glucose; Body Weight; Defecation; Double-Blind Method; Female; Gastric Emptying; Glutamine; Head; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Length of Stay; Liver; Liver Diseases; Male; Parenteral Nutrition, Total; Protective Agents; Respiration, Artificial; Time Factors | 2010 |
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.
Topics: Aged; Biomarkers; Carcinoma, Hepatocellular; Diagnosis, Differential; Dipeptides; Fatty Liver; Female; Glutamine; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Male; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protein Array Analysis; Reproducibility of Results | 2011 |
58 other study(ies) available for glutamine and Liver Dysfunction
Article | Year |
---|---|
A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation.
Topics: Ammonia; Animals; Bile Acids and Salts; Bile Ducts; Brain; Choline; Disease Models, Animal; Glutamine; Hepatic Encephalopathy; Hyperammonemia; Kynurenine; Liver Diseases; Mice; Microglia; Neuroinflammatory Diseases; Rats; Taurine; Tryptophan | 2022 |
Neurometabolic changes in a rat pup model of type C hepatic encephalopathy depend on age at liver disease onset.
Topics: Adult; Animals; Brain; Child; Glutamine; Hepatic Encephalopathy; Humans; Lactic Acid; Liver Diseases; Magnetic Resonance Spectroscopy; Rats | 2023 |
Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.
Topics: Ammonia; Animals; Arginase; Arginine; Codon; Disease Models, Animal; Glutamine; Hyperammonemia; Hyperargininemia; Lipids; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Nanoparticles; RNA, Messenger; Urea | 2019 |
Longitudinal osmotic and neurometabolic changes in young rats with chronic cholestatic liver disease.
Topics: Animals; Aquaporin 4; Brain; Cholestasis; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glutamine; Hepatic Encephalopathy; Hippocampus; Immunohistochemistry; Liver Diseases; Magnetic Resonance Spectroscopy; Male; Neurotransmitter Agents; Osmosis; Rats; Rats, Wistar | 2020 |
Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease.
Topics: Ammonium Compounds; Animals; Behavior, Animal; Bifidobacterium; Bile Ducts; Bilirubin; Blood Glucose; Body Weight; Brain; Cholestasis; Disease Progression; Feces; Gastrointestinal Microbiome; Glutamine; Inositol; Ligation; Liver Diseases; Male; Metabolome; Probiotics; Proton Magnetic Resonance Spectroscopy; Rats, Wistar | 2021 |
A review of enteral strategies in infant short bowel syndrome: evidence-based or NICU culture?
Topics: Atrophy; Case-Control Studies; Cohort Studies; Combined Modality Therapy; Critical Care; Diarrhea, Infantile; Dietary Fats; Dietary Fiber; Enteral Nutrition; Evidence-Based Medicine; Exocrine Pancreatic Insufficiency; Food, Formulated; Gastrointestinal Agents; Gastrointestinal Hormones; Gastrointestinal Motility; Glutamine; Humans; Infant; Infant Food; Infant, Newborn; Intensive Care Units, Neonatal; Liver Diseases; Pancreas, Exocrine; Pancreatic Extracts; Parenteral Nutrition; Peptides; Probiotics; Randomized Controlled Trials as Topic; Short Bowel Syndrome | 2013 |
Increased brain lactate is central to the development of brain edema in rats with chronic liver disease.
Topics: Ammonia; Animals; Brain; Brain Edema; Chronic Disease; Glutamine; Hepatic Encephalopathy; Lactic Acid; Liver Diseases; Male; Rats; Rats, Sprague-Dawley | 2014 |
Glutamine provides effective protection against deltamethrin-induced acute hepatotoxicity in rats but not against nephrotoxicity.
Topics: Animals; Glutamine; Kidney Diseases; Kidney Tubules; Liver Diseases; Male; Nitriles; Protective Agents; Pyrethrins; Rats, Wistar | 2015 |
[Function of zinc in liver disease].
Topics: Ammonia; Glutamine; Humans; Liver Diseases; Urea; Zinc | 2016 |
Magnetic Resonance Spectroscopy for Evaluating Portal-Systemic Encephalopathy in Patients with Chronic Hepatic Schistosomiasis Japonicum.
Topics: Aged; Aged, 80 and over; Ammonia; Brain; Chronic Disease; Female; Globus Pallidus; Glutamine; Hepatic Encephalopathy; Humans; Lactic Acid; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Schistosomiasis japonica | 2016 |
Pseudodeficiency of glutamine in infant liver disease.
Topics: Cholestasis; gamma-Glutamyltransferase; Glutamic Acid; Glutamine; Humans; Infant; Liver Diseases; Male | 2009 |
Reduction of liver ischemia-reperfusion injury via glutamine pretreatment.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Dipeptides; Disease Models, Animal; Glutamine; In Situ Nick-End Labeling; Ischemic Preconditioning; Laser-Doppler Flowmetry; Liver Circulation; Liver Diseases; Male; Microcirculation; Oxidation-Reduction; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2011 |
Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation.
Topics: Amino Acid Sequence; Animals; Glutamine; GTP-Binding Proteins; Hepatocytes; Intermediate Filaments; Keratin-8; Liver Diseases; Mallory Bodies; Mice; Mice, Transgenic; Phosphorylation; Protein Glutamine gamma Glutamyltransferase 2; Transglutaminases | 2012 |
Effect of L-arginine supplement on liver regeneration after partial hepatectomy in rats.
Topics: Administration, Oral; Alanine; Animals; Arginine; DNA; Glutamine; Hepatectomy; Immunoenzyme Techniques; Liver Diseases; Liver Regeneration; Male; Polymerase Chain Reaction; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; RNA | 2012 |
Tissue-protective effect of glutamine on hepatic ischemia-reperfusion injury via induction of heme oxygenase-1.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemokine CCL2; Glutamine; Heme Oxygenase (Decyclizing); L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Protective Agents; Rats; Rats, Wistar; Regional Blood Flow; Reperfusion Injury; Thiobarbituric Acid Reactive Substances | 2013 |
Effects of oral arginine and glutamine on radiation-induced injury in the rat.
Topics: Administration, Oral; Animals; Arginine; Aspartate Aminotransferases; Diarrhea; Dietary Supplements; Glutamine; Intestinal Diseases; Intestines; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Models, Animal; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley | 2003 |
GLUTAMATE and arginine treatment of ammonium toxicity.
Topics: Ammonia; Ammonium Compounds; Arginine; Glutamates; Glutamic Acid; Glutamine; Humans; Liver Diseases | 1957 |
Levels of glutamine and ammonia and the pH of cerebrospinal fluid and plasma in patients with liver disease.
Topics: Ammonia; Blood; Blood Chemical Analysis; Cerebrospinal Fluid; Glutamine; Humans; Hydrogen-Ion Concentration; Liver Diseases; Metabolic Diseases; Plasma | 1962 |
[Value of the determination of glutamine in the cerebrospinal fluid in hepatic diseases].
Topics: Cerebrospinal Fluid; Glutamine; Liver Diseases | 1962 |
GLUTAMINE SYNTHETASE. II. THE INTRACELLULAR LOCALIZATION IN THE RAT LIVER.
Topics: Bile Acids and Salts; Glutamate-Ammonia Ligase; Glutamine; Ligases; Liver; Liver Diseases; Liver Regeneration; Rats; Research; Ribonucleases; Salts; Sodium Chloride; Transferases | 1963 |
STUDIES OF RAT LIVER AND KIDNEY ENZYMES. I. RESPONSE TO MASSIVE INTRAGASTRIC DOSES OF CHRONICALLY ADMINISTERED NITROGENOUS SUBSTANCES.
Topics: Alanine; Amino Acids; Ammonia; Arginine; Brain Diseases; Enzymes; Glutamates; Glutamine; Injections; Kidney; Liver; Liver Diseases; Nitrogen; Ornithine; Rats; Research; Stomach; Transaminases; Urea | 1964 |
[CLINICAL SIGNIFICANCE OF THE DETERMINATION OF GLUTAMINE IN THE CEREBROSPINAL FLUID. (RESULTS IN 50 CASES)].
Topics: Cerebrospinal Fluid; Diagnosis, Differential; Glutamine; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Liver Diseases; Metabolism; Pathology | 1964 |
[CLINICAL SIGNIFICANCE OF THE DETERMINATION OF CEREBROSPINAL FLUID GLUTAMINE].
Topics: Ammonia; Blood; Cerebrospinal Fluid; Glutamine; Liver Diseases | 1964 |
GLUTAMINE SYNTHETASE. IV.ITS FORMATION IN RAT LIVER FOLLOWING PARTIAL HEPATECTOMY AND DURING REPLETION.
Topics: Brain; Caseins; Dietary Proteins; DNA; Fasting; Glutamate-Ammonia Ligase; Glutamine; Hepatectomy; Humans; Kidney; Ligases; Liver; Liver Diseases; Liver Regeneration; Male; Nephrectomy; Rats; Research; Testis | 1964 |
[The diagnostic value of serum leucine aminopeptidase, alkaline phosphatase and glutamine oxalacetic acid transaminase activity. Comparative studies].
Topics: Alkaline Phosphatase; Biliary Tract; Biliary Tract Diseases; Coloring Agents; Glutamine; Humans; Leucyl Aminopeptidase; Liver Diseases; Oxaloacetic Acid; Peptide Hydrolases; Phosphoric Monoester Hydrolases; Transaminases | 1961 |
Brain amino acid abnormalities in liver disease--a postmortem study.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Brain; Case-Control Studies; Forensic Medicine; Glutamine; Humans; Liver Diseases; Molecular Structure; Ornithine; Proline | 2003 |
Glutamine attenuates TPN-associated liver injury in infant rabbits.
Topics: Animals; Animals, Newborn; Apoptosis; Glutamine; In Situ Nick-End Labeling; Liver Diseases; Liver Function Tests; Parenteral Nutrition, Total; Rabbits | 2007 |
[Methods of serum enzyme determination and its clinical significance: gamma-glutamyl transpeptidase].
Topics: 1-Carboxyglutamic Acid; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestasis, Extrahepatic; Female; gamma-Glutamyltransferase; Glutamates; Glutamine; Humans; Infant; Infant, Newborn; Liver Diseases; Male; Methods; Middle Aged; Pancreatic Diseases; Substrate Specificity | 1983 |
[Glutamine in cerebrospinal fluid in the diagnosis of altered consciousness of hepatic origin].
Topics: Adolescent; Adult; Aged; Cognition Disorders; Consciousness Disorders; Female; Glutamine; Hepatic Encephalopathy; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1984 |
[Functional liver cell heterogeneity].
Topics: Acid-Base Equilibrium; Amino Acids; Ammonia; Energy Metabolism; Enzymes; Glutamine; Humans; Inactivation, Metabolic; Liver; Liver Diseases; Pharmaceutical Preparations; Urea | 1984 |
Hepatocyte heterogeneity in ammonia metabolism: impairment of glutamine synthesis in CCl4 induced liver cell necrosis with no effect on urea synthesis.
Topics: Ammonia; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glutamine; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains; Urea | 1984 |
Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.
Topics: Acute Disease; Biomarkers; Carcinoma, Hepatocellular; Chronic Disease; Fatty Liver, Alcoholic; gamma-Glutamyltransferase; Glutamates; Glutamic Acid; Glutamine; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Liver Diseases, Alcoholic; Liver Neoplasms; Temperance | 1993 |
Effect of dietary L-glutamine on the hepatotoxic action of D-galactosamine in rats.
Topics: Alanine; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Diet; Galactosamine; Glutamic Acid; Glutamine; L-Lactate Dehydrogenase; Liver Diseases; Male; Neomycin; Rats; Rats, Wistar; Stereoisomerism | 1996 |
A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy.
Topics: 1,4-alpha-Glucan Branching Enzyme; Amino Acid Substitution; Arginine; Base Sequence; Cytoplasmic Granules; Glutamine; Glycogen Storage Disease Type IV; Heterozygote; Humans; Infant; Liver; Liver Diseases; Male; Muscle, Skeletal; Muscular Diseases; Mutation, Missense | 1999 |
Glutamine and glutathione counteract the inhibitory effects of mediators of sepsis in neonatal hepatocytes.
Topics: Animals; Citric Acid Cycle; Glutamine; Glutathione; Hepatocytes; Hydrogen Peroxide; Liver Diseases; Nitric Oxide; Rats; Rats, Wistar; Sepsis | 2001 |
Labelling of glutamine acid with 113mIn for scintigraphic examinations of liver and spleen.
Topics: Animals; Glutamine; Humans; Indium; Isotope Labeling; Liver Diseases; Rabbits; Radionuclide Imaging; Splenic Diseases | 1976 |
[Psychiatric-neurological disorders in chronic liver diseases].
Topics: Acute Disease; Ammonia; Biotransformation; Brain Damage, Chronic; Brain Diseases; Chronic Disease; Dietary Proteins; Diuretics; Glutamine; Humans; Lactulose; Liver Diseases; Mental Disorders; Portacaval Shunt, Surgical; Postoperative Complications; Prognosis | 1975 |
Muscle nitrogen metabolism in chronic hepatic insufficiency.
Topics: Adult; Aged; Alanine; Alcoholism; Amino Acids; Ammonia; Brachial Artery; Female; Forearm; Glutamine; Hepatic Encephalopathy; Humans; Lactates; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Muscles; Nitrogen; Pyruvates; Veins | 1976 |
Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.
Topics: Aspartic Acid; Brain; Choline; Female; Glucose; Glutamates; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Liver Diseases; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphocreatine; Reproducibility of Results | 1992 |
Glutamine preserves liver glutathione after lethal hepatic injury.
Topics: Acetaminophen; Analysis of Variance; Animals; Chemical and Drug Induced Liver Injury; Glutamine; Glutathione; Linear Models; Liver; Liver Diseases; Liver Function Tests; Male; Parenteral Nutrition, Total; Rats; Rats, Inbred Strains; Survival Analysis | 1992 |
Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem.
Topics: Acute Disease; Astrocytes; Brain Edema; Glutamine; Humans; Intracranial Pressure; Liver Diseases; Sodium-Potassium-Exchanging ATPase | 1991 |
Observation of cerebral metabolites in an animal model of acute liver failure in vivo: a 1H and 31P nuclear magnetic resonance study.
Topics: Acute Disease; Animals; Biomarkers; Brain; Glutamates; Glutamic Acid; Glutamine; Hydrogen; Lactates; Lactic Acid; Liver Diseases; Magnetic Resonance Spectroscopy; Male; Phosphorus; Rats; Rats, Inbred Strains | 1989 |
Cerebral metabolism during cross-circulation in experimental hepatic failure in the pig.
Topics: Ammonia; Animals; Blood Glucose; Brain; Cross Circulation; Glucose; Glutamates; Glutamic Acid; Glutamine; Ketoglutaric Acids; Liver; Liver Diseases; Oxygen Consumption; Parabiosis; Potassium; Sodium; Swine | 1986 |
Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver disease.
Topics: Acetazolamide; Ammonia; Bicarbonates; Chronic Disease; Glutamine; Humans; Liver; Liver Diseases; Urea | 1988 |
Dynamic relationship between urea and glutamine synthesis in the mechanism of ammonia detoxication: a tracer study using 15NH4Cl in fulminant hepatic failure rats.
Topics: Ammonia; Ammonium Chloride; Animals; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Galactosamine; Glutamine; Liver Diseases; Male; Nitrogen Isotopes; Rats; Rats, Inbred Strains; Urea | 1988 |
Laboratory tests and diagnostic procedures in evaluation of liver disease.
Topics: Brain Diseases; Glutamine; Humans; Liver Diseases | 1986 |
Metabolism of branched-chain amino acids in rats with acute hepatic failure: a tracer study using 15N-leucine.
Topics: Alanine; Amino Acids, Branched-Chain; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Glucagon; Glutamine; Insulin; Isoleucine; Leucine; Liver Diseases; Male; Rats; Rats, Inbred Strains; Valine | 1985 |
[Serum gamma glutamyl transpeptidase in hepatobiliary diseases. Comparison with alkaline phosphatase and aryl amidase].
Topics: Acute Disease; Alanine Transaminase; Alkaline Phosphatase; Aminopeptidases; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Chronic Disease; Glutamine; Hepatitis; Humans; Leucyl Aminopeptidase; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Pancreatitis | 1972 |
Rapid determination of ammonia in a perchloric acid supernate from blood, by use of an ammonia-specific electrode.
Topics: Amides; Ammonia; Chemical Precipitation; Electrodes; Glutamine; Humans; Hydrogen-Ion Concentration; Hydrolysis; Ion Exchange Resins; Liver Diseases; Mathematics; Methods; Perchlorates; Sodium Chloride; Temperature; Time Factors | 1973 |
Identification of alpha-ketoglutaramate in rat liver, kidney, and brain. Relationship to glutamine transaminase and omega-amidase activities.
Topics: Amides; Amidohydrolases; Animals; Brain; Brain Chemistry; Carbon Radioisotopes; Chromatography, Ion Exchange; Glutamine; Humans; Isotope Labeling; Ketoglutaric Acids; Kidney; Liver; Liver Diseases; Rats; Transaminases; Ultrafiltration | 1974 |
[Treatment of acute hepatic insufficiency].
Topics: Animals; Glucocorticoids; Glutamine; Humans; Hyperbaric Oxygenation; Liver Diseases; Liver Transplantation; Plasmapheresis; Renal Dialysis; Swine; Transplantation, Heterologous | 1972 |
Ultrastructural responses of the astrocytes to portocaval anastomosis in the rat.
Topics: Ammonia; Animals; Brain; Brain Diseases; Carbon Tetrachloride Poisoning; Caudate Nucleus; Cerebellar Nuclei; Chemical and Drug Induced Liver Injury; Cytoplasm; Disease Models, Animal; Glutamates; Glutamine; Liver Diseases; Male; Microscopy, Electron; Nerve Degeneration; Nerve Fibers, Myelinated; Neuroglia; Nitrosamines; Portacaval Shunt, Surgical; Rats | 1973 |
Alpha-ketoglutaramate: increased concentrations in the cerebrospinal fluid of patients in hepatic coma.
Topics: Amides; Ammonia; Animals; Depression, Chemical; Dose-Response Relationship, Drug; Glutamates; Glutamine; Hepatic Encephalopathy; Humans; Ketoglutaric Acids; Liver Diseases; Motor Activity; Myoclonus; Rats; Respiratory Insufficiency | 1974 |
Hyperammonaemia and spongy degeneration of the brain in sheep affected with hepatic necrosis.
Topics: Ammonia; Animals; Brain; Brain Diseases; Chemical and Drug Induced Liver Injury; Glutamine; Liver; Liver Diseases; Male; Necrosis; Pyrrolizidine Alkaloids; Sheep; Sheep Diseases | 1974 |
[Comparison of the results of ion-exchange chromatographic and enzymatic determination of human serum glutamine].
Topics: Chromatography, Ion Exchange; Clinical Enzyme Tests; Glutaminase; Glutamine; Humans; Liver Diseases; Methods | 1970 |
[Glutamine levels of the cerebrospinal fluid. Study of 101 children].
Topics: Child, Preschool; Glutamine; Humans; Infant; Liver Diseases; Nervous System Diseases | 1970 |
[Excretion of phenylacetylglutamine in liver diseasses].
Topics: Glutamine; Humans; Liver Diseases; Phenylacetates; Phenylalanine | 1968 |
[NH4+ determination using an enzymatic micromethod in surgical conditions].
Topics: Blood Proteins; Clinical Enzyme Tests; Glutamate Dehydrogenase; Glutamine; Humans; Ketoglutaric Acids; Liver Diseases; Microchemistry; Quaternary Ammonium Compounds; Trichloroacetic Acid | 1966 |